Endovenous Lidocaine and Serum Cytokines Concentration

PHASE4CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

January 31, 2014

Conditions
Cholelithiasis
Interventions
DRUG

Lidocaine

Lidocaine was administered in bolus of 1.5 mg.kg-1 at the start of the procedure and maintained at a dose of 3 mg.kg-1.h-1 until one hour after the end of the procedure. Solution of 0,3% lidocaine was used, so that the infusion rate was equal to the weight of the patient.

DRUG

Saline solution

Saline solution was administered in bolus of 1.5 mg.kg-1 at the start of the procedure and maintained at a dose of 3 mg.kg-1.h-1 until one hour after the end of the procedure.

All Listed Sponsors
collaborator

Universidade Federal de Santa Catarina

OTHER

lead

Universidade Federal de Santa Maria

OTHER

NCT02363699 - Endovenous Lidocaine and Serum Cytokines Concentration | Biotech Hunter | Biotech Hunter